Benjamin Heyman

781 total citations
24 papers, 468 citations indexed

About

Benjamin Heyman is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Benjamin Heyman has authored 24 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Genetics and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Benjamin Heyman's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and CAR-T cell therapy research (9 papers). Benjamin Heyman is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and CAR-T cell therapy research (9 papers). Benjamin Heyman collaborates with scholars based in United States, United Kingdom and Australia. Benjamin Heyman's co-authors include Yiping Yang, Amy J. Petty, Rui Dai, David S. Hsu, Ang Li, Xiaopei Huang, Thomas J. Kipps, Anne Beaven, Michael Y. Choi and Sylvia F. Costa and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin Heyman

20 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Heyman United States 9 184 183 170 52 44 24 468
Andrea Arruda Canada 10 163 0.9× 255 1.4× 188 1.1× 50 1.0× 23 0.5× 39 566
Mina O. Seedhom United States 8 209 1.1× 271 1.5× 148 0.9× 30 0.6× 26 0.6× 14 503
Fanny Lafouresse France 14 261 1.4× 515 2.8× 171 1.0× 46 0.9× 28 0.6× 18 757
Archana Panikkar Australia 11 149 0.8× 104 0.6× 194 1.1× 79 1.5× 41 0.9× 19 594
Jessica Michie Australia 8 330 1.8× 329 1.8× 225 1.3× 43 0.8× 16 0.4× 10 545
Aaron Y. Chang United States 13 405 2.2× 336 1.8× 249 1.5× 30 0.6× 58 1.3× 18 709
R. Katherine Hyde United States 15 108 0.6× 96 0.5× 349 2.1× 44 0.8× 20 0.5× 30 562
Melisa Martinez-Paniagua United States 11 109 0.6× 123 0.7× 173 1.0× 37 0.7× 61 1.4× 24 368
Rancés Blanco Cuba 15 237 1.3× 206 1.1× 303 1.8× 107 2.1× 28 0.6× 45 607
Lyndsay Avery United States 11 210 1.1× 421 2.3× 109 0.6× 35 0.7× 32 0.7× 12 579

Countries citing papers authored by Benjamin Heyman

Since Specialization
Citations

This map shows the geographic impact of Benjamin Heyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Heyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Heyman more than expected).

Fields of papers citing papers by Benjamin Heyman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Heyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Heyman. The network helps show where Benjamin Heyman may publish in the future.

Co-authorship network of co-authors of Benjamin Heyman

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Heyman. A scholar is included among the top collaborators of Benjamin Heyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Heyman. Benjamin Heyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Tushar & Benjamin Heyman. (2025). Updates on the Treatment of Richter’s Syndrome, Including Novel Combination Approaches. Cancers. 17(6). 943–943.
2.
Pineda, Cristiana M., Benjamin Heyman, Deepa Rangachari, et al.. (2025). Patterns of HER2 expression and genomic correlates in lung cancer, with a focus on preanalytical variables impacting immunohistochemical staining results. Journal of Clinical Pathology. 79(1). 24–30. 1 indexed citations
3.
Heyman, Benjamin, et al.. (2025). Antibody Therapy for Patients with Lymphoid Malignancies: Past and Present. International Journal of Molecular Sciences. 26(4). 1711–1711. 3 indexed citations
4.
Heyman, Benjamin, Michael Y. Choi, & Thomas J. Kipps. (2024). A + AVD for Treatment of Hodgkin Lymphoma Variant of Richter’s Transformation. SHILAP Revista de lepidopterología. 2024. 1–8.
5.
Botta, Gregory P., Joseph Chao, H. Ma, et al.. (2024). Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells. Journal for ImmunoTherapy of Cancer. 12(2). e007927–e007927. 15 indexed citations
6.
Heyman, Benjamin, Stephen Opat, Björn E. Wahlin, et al.. (2024). Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia. Blood Advances. 9(4). 722–728. 3 indexed citations
7.
Choi, Michael Y., et al.. (2023). Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach. Cancers. 15(18). 4483–4483. 3 indexed citations
8.
Heyman, Benjamin, Michael Y. Choi, & Thomas J. Kipps. (2023). Comparison of Venetoclax Based Treatments for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood. 142(Supplement 1). 1907–1907.
9.
Heyman, Benjamin, Mohammed Nabeel, Ahmad Al Badawi, et al.. (2023). RPU: The Ring Processing Unit. 272–282. 13 indexed citations
10.
Heyman, Benjamin, Dimitrios Tzachanis, & Thomas J. Kipps. (2022). Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia. Cancers. 14(7). 1715–1715. 10 indexed citations
11.
Heyman, Benjamin, Michael Y. Choi, & Thomas J. Kipps. (2022). Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter’s Syndrome. Cancers. 14(24). 6035–6035. 5 indexed citations
12.
Petty, Amy J., Benjamin Heyman, & Yiping Yang. (2020). Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer. Cancers. 12(4). 842–842. 24 indexed citations
13.
Heyman, Benjamin, Michael Y. Choi, Emanuela M. Ghia, et al.. (2020). Cirmtuzumab Consolidation for Treatment of Patients with Detectable CLL on Venetoclax. Blood. 136(Supplement 1). 13–13.
14.
Petty, Amy J., Ang Li, Rui Dai, et al.. (2019). Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment. Journal of Clinical Investigation. 129(12). 5151–5162. 218 indexed citations
15.
Dunn‐Pirio, Anastasie, Benjamin Heyman, Dan S. Kaufman, & Revere P. Kinkel. (2019). Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple Sclerosis. Current Treatment Options in Neurology. 21(10). 53–53. 5 indexed citations
16.
Heyman, Benjamin & Yiping Yang. (2018). New developments in immunotherapy for lymphoma. Cancer Biology and Medicine. 15(3). 189–189. 17 indexed citations
17.
Heyman, Benjamin & Anne Beaven. (2018). Mycophenolate Mofetil for the Treatment of Subcutaneous Panniculitis-Like T-Cell Lymphoma: Case Report and Review of the Literature. Clinical Lymphoma Myeloma & Leukemia. 18(10). e437–e440. 8 indexed citations
18.
Heyman, Benjamin, David A. Rizzieri, David J. Adams, et al.. (2018). Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 18(10). 679–686. 2 indexed citations
19.
Heyman, Benjamin & Yiping Yang. (2016). Mechanisms of heparanase inhibitors in cancer therapy. Experimental Hematology. 44(11). 1002–1012. 45 indexed citations
20.
Barnett, Adam S., Kara Wegermann, Andrew D. Strand, et al.. (2016). Diagnosis of Capnocytophaga canimorsus Sepsis by Whole-Genome Next-Generation Sequencing. Open Forum Infectious Diseases. 3(3). ofw144–ofw144. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Arruda Breakdown of academic impact, for papers by Mina O. Seedhom Breakdown of academic impact, for papers by Fanny Lafouresse Breakdown of academic impact, for papers by Archana Panikkar Breakdown of academic impact, for papers by Jessica Michie Breakdown of academic impact, for papers by Aaron Y. Chang Breakdown of academic impact, for papers by R. Katherine Hyde Breakdown of academic impact, for papers by Melisa Martinez-Paniagua Breakdown of academic impact, for papers by Rancés Blanco Breakdown of academic impact, for papers by Lyndsay Avery
Rankless by CCL
2026